Premium Company

Established in 1966, Kalbe has gone a long way from a humble operation that started in a garage to become the leading pharmaceutical company in Indonesia. Growing both organically and through mergers & acquisitions, Kalbe expands its business interests and transformed itself to become a provider of an integrated healthcare solution through its 4 business divisions: the Prescription Pharmaceutical Division, Consumer Health Division, Nutritionals Division, and Distribution and Logistics Division. These business divisions manage an extensive portfolio of prescription pharmaceuticals and OTC drugs, energy drink and nutrition products, as well as a robust distribution arm serving over one million outlets across Indonesia’s vast archipelago. In the international market, the Company has established its footprint in ASEAN countries, Nigeria, and South Africa, positioning Kalbe as a national pharmaceutical company with a competitive edge in the export market. Since its founding, the Company has been aware of the importance of innovation to grow its business. Kalbe Farma has established a robust research and development activities in leading-edge generic drug formulation and continuous development of innovative consumer and nutritional products. Through strategic alliances with international partners, Kalbe has also started to support several successful research and development venture working on cancer drugs, stem cells, and biotechnology research. 12 GMP facilities complying with international standards The manufacturing facilities of Kalbe Group produce pharmaceuticals, biologics, consumers, nutrition, beverages and stem cells products located in Indonesia and Nigeria, with capabilities in solid, liquid, semi-solid and sterile dosage forms. Those facilities are ISO 9001, ISO 14001, OHSAS 18001 certified, comply with WHO GMP compliance, EU GMP compliance, TGA compliance. 

Sales Markets

Asia; Africa

Contact information




View All Contact Info